Increased Overall Survival for Subcutaneous Versus Intravenous Daratumumab in Medicare Beneficiaries With Multiple Myeloma
- DOI
- 10.1016/j.clml.2026.08.016
- Published
- 2026-11
- Container
- Clinical Lymphoma Myeloma and Leukemia
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clml.2026.08.016,
title = {Increased Overall Survival for Subcutaneous Versus Intravenous Daratumumab in Medicare Beneficiaries With Multiple Myeloma},
author = {Daniel Gomes and Phillip Sarocco and Charles P. Theuer and Gareth Morgan and Todd Kennedy and Paul Santos Estrella and Jimmy Zhou and Saad Z. Usmani},
year = {2026},
journal = {Clinical Lymphoma Myeloma and Leukemia},
doi = {10.1016/j.clml.2026.08.016},
url = {https://doi.org/10.1016/j.clml.2026.08.016}
}RIS
TY - JOUR TI - Increased Overall Survival for Subcutaneous Versus Intravenous Daratumumab in Medicare Beneficiaries With Multiple Myeloma AU - Daniel Gomes AU - Phillip Sarocco AU - Charles P. Theuer AU - Gareth Morgan AU - Todd Kennedy AU - Paul Santos Estrella AU - Jimmy Zhou AU - Saad Z. Usmani PY - 2026 JO - Clinical Lymphoma Myeloma and Leukemia DO - 10.1016/j.clml.2026.08.016 UR - https://doi.org/10.1016/j.clml.2026.08.016 ER -
APA
Gomes, D., Sarocco, P., Theuer, C. P., Morgan, G., Kennedy, T., Estrella, P. S., Zhou, J., & Usmani, S. Z. (2026). Increased Overall Survival for Subcutaneous Versus Intravenous Daratumumab in Medicare Beneficiaries With Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2026.08.016
Source records
- crossref · retrieved 2026-11-10T10:05:35.338Z